SAT-019 ACEi/ARBs, β-blockers or Both in incident End-Stage Renal Disease patients without Cardiovascular Disease: A Propensity-Matched longitudinal study in a Nationwide cohort

摘要

End-stage renal disease (ESRD) patients even without known cardiovascular (CV) disease have high mortality rates. Whether neuro-hormonal blockade treatments improve outcomes in this popu- Jation remains unknown.